Rethinking the Development of CAR T-Cell Products for Pediatric Cancer

In a commentary published in the Journal of Clinical Oncology, Claudia Rossig, MD, of the department of pediatric hematology and oncology at the University Children’s Hospital Muenster in Muenster, Germany, and coauthors reviewed the challenges and opportunities in developing of CAR T-cell therapies for pediatric cancers. They also discussed alternative development pathways for CAR T-cell products.

Read more: